442P A phase I-II multicenter trial with avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients. GEMCAD 16-02 (AVEVAC trial)
- Resource Type
- Abstract
- Authors
- Español-Rego, M.; Fernández-Martos, C.; Fernandez, M.E. Elez; Foguet, C.; Pedrosa, L.; Rodríguez, N.; Ruiz, A.; Pineda, E.; Cid, J.; Cabezón, R.; Oliveres, H.; Lozano, M.; Ginés, A.; Garcia-Criado, A.; Cuatrecasas, M.; Torres, F.; Cascante, M.; Benítez-Ribas, D.; Maurel, J.
- Source
- In Annals of Oncology September 2021 32 Supplement 5:S555-S555
- Subject
- Language
- ISSN
- 0923-7534